TOVORAFENIB

TOVORAFENIB was reported 326 times

These side effects are most commonly reported by patients taking TOVORAFENIB:

# Side effect Count
0 OFF LABEL USE 34
1 DISEASE PROGRESSION 28
2 RASH 27
3 FATIGUE 23
4 ACCIDENTAL UNDERDOSE 19
5 HAIR COLOUR CHANGES 18
6 HEADACHE 17
7 MELANOCYTIC NAEVUS 15
8 GROWTH RETARDATION 12
9 BLOOD CREATINE PHOSPHOKINASE INCREASED 11
10 NAUSEA 11
11 ACNE 10
12 DERMATITIS ACNEIFORM 10
13 INTRACRANIAL TUMOUR HAEMORRHAGE 10
14 PHOTOSENSITIVITY REACTION 9
15 BLOOD PHOSPHORUS DECREASED 8
16 WEIGHT DECREASED 8
17 ANAEMIA 7
18 DEATH 7
19 CONSTIPATION 6
20 EPHELIDES 6
21 VOMITING 6
22 AMENORRHOEA 5
23 ASTHENIA 5
24 DECREASED APPETITE 5
25 ERYTHEMA 5
26 INSOMNIA 5
27 MYALGIA 5
28 PAIN 5
29 PRODUCT ADMINISTRATION ERROR 5
30 PRURITUS 5
31 TUMOUR HAEMORRHAGE 5
32 ARTHRALGIA 4
33 BLOOD BILIRUBIN INCREASED 4
34 EPISTAXIS 4
35 HAEMOGLOBIN DECREASED 4
36 MUSCULOSKELETAL STIFFNESS 4
37 NO ADVERSE EVENT 4
38 PNEUMONIA 4
39 SEIZURE 4
40 SOMNOLENCE 4
41 ADVERSE DRUG REACTION 3
42 ALOPECIA 3
43 ANXIETY 3
44 BLISTER 3
45 CELLULITIS 3
46 CREATINE KINASE INCREASED 3
47 DEVICE OCCLUSION 3
48 DIZZINESS 3
49 DRUG INEFFECTIVE 3
50 DRY SKIN 3
51 HAEMATOTOXICITY 3
52 HEPATIC CYTOLYSIS 3
53 HERPES ZOSTER MENINGOENCEPHALITIS 3
54 HYPONATRAEMIA 3
55 HYPOPHOSPHATAEMIA 3
56 LYMPHADENOPATHY 3
57 PAIN IN EXTREMITY 3
58 PERICARDIAL EFFUSION 3
59 PRODUCT DOSE OMISSION ISSUE 3
60 PRODUCT USE COMPLAINT 3
61 PRODUCT USE ISSUE 3
62 PYREXIA 3
63 SKIN HYPERPIGMENTATION 3
64 SWELLING FACE 3
65 ACCIDENTAL OVERDOSE 2
66 ADRENAL INSUFFICIENCY 2
67 AGITATION 2
68 ASPARTATE AMINOTRANSFERASE INCREASED 2
69 BALANCE DISORDER 2
70 BLEPHARITIS 2
71 CEREBRAL ASPERGILLOSIS 2
72 CEREBRAL HAEMORRHAGE 2
73 CONJUNCTIVITIS 2
74 CONTUSION 2
75 COORDINATION ABNORMAL 2
76 COUGH 2
77 DEVICE MALFUNCTION 2
78 DEVICE RELATED INFECTION 2
79 DRUG ERUPTION 2
80 ECZEMA 2
81 EOSINOPHILIA 2
82 GASTROINTESTINAL DISORDER 2
83 HAEMORRHAGE 2
84 HAEMORRHAGIC CYST 2
85 HEART RATE INCREASED 2
86 HEPATIC ENZYME ABNORMAL 2
87 HYPERBILIRUBINAEMIA 2
88 HYPERCALCAEMIA 2
89 INCORRECT DOSE ADMINISTERED 2
90 LETHARGY 2
91 LEUKOPENIA 2
92 LIVER FUNCTION TEST INCREASED 2
93 MACULE 2
94 METASTASES TO MENINGES 2
95 NIGHT SWEATS 2
96 OROPHARYNGEAL PAIN 2
97 PERIPHERAL SWELLING 2
98 PHARYNGITIS STREPTOCOCCAL 2
99 PLEURAL EFFUSION 2
100 PRODUCT COMMUNICATION ISSUE 2
101 PRODUCT PHYSICAL ISSUE 2
102 PRODUCT RECONSTITUTION QUALITY ISSUE 2
103 PRODUCT SOLUBILITY ABNORMAL 2
104 RASH MACULO-PAPULAR 2
105 RHABDOMYOLYSIS 2
106 SKIN DISCOLOURATION 2
107 SKIN DISORDER 2
108 SKIN HYPOPIGMENTATION 2
109 SKIN LACERATION 2
110 SKIN TOXICITY 2
111 STAPHYLOCOCCAL INFECTION 2
112 STOMATITIS 2
113 SWELLING 2
114 THERAPY NON-RESPONDER 2
115 THROMBOCYTOPENIA 2
116 UPPER RESPIRATORY TRACT INFECTION 2
117 WEIGHT INCREASED 2
118 ABDOMINAL DISCOMFORT 1
119 ABDOMINAL PAIN 1
120 ABSCESS LIMB 1
121 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1
122 ACUTE HAEMORRHAGIC CONJUNCTIVITIS 1
123 ADENOVIRUS INFECTION 1
124 AGEUSIA 1
125 ALANINE AMINOTRANSFERASE ABNORMAL 1
126 ALANINE AMINOTRANSFERASE INCREASED 1
127 AMAUROSIS 1
128 AMNESIA 1
129 ANAPHYLACTIC REACTION 1
130 ANGIOEDEMA 1
131 ARTHROPATHY 1
132 ASPARTATE AMINOTRANSFERASE ABNORMAL 1
133 ASPIRATION 1
134 ATELECTASIS 1
135 ATRIOVENTRICULAR BLOCK 1
136 B-CELL LYMPHOMA 1
137 BACTERAEMIA 1
138 BLOOD PROLACTIN INCREASED 1
139 BLOOD SODIUM DECREASED 1
140 BRAIN OEDEMA 1
141 BRAIN OPERATION 1
142 C-REACTIVE PROTEIN INCREASED 1
143 CARDIAC DISORDER 1
144 CELLULITIS STAPHYLOCOCCAL 1
145 CENTRAL HYPOTHYROIDISM 1
146 CENTRAL PAIN SYNDROME 1
147 CEREBRAL CYST 1
148 CEREBRAL HAEMATOMA 1
149 CEREBRAL ISCHAEMIA 1
150 CEREBRAL MICROHAEMORRHAGE 1
151 COMPARTMENT SYNDROME 1
152 CONDITION AGGRAVATED 1
153 CONFUSIONAL STATE 1
154 CORNEAL INFILTRATES 1
155 COVID-19 1
156 COVID-19 PNEUMONIA 1
157 CUTIBACTERIUM ACNES INFECTION 1
158 CYSTITIS 1
159 CYTOPENIA 1
160 DEMYELINATION 1
161 DERMATITIS 1
162 DIABETES INSIPIDUS 1
163 DIABETES MELLITUS 1
164 DIARRHOEA 1
165 DIPLOPIA 1
166 DISSEMINATED ASPERGILLOSIS 1
167 DRUG HYPERSENSITIVITY 1
168 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1
169 DRY MOUTH 1
170 DYSPHAGIA 1
171 EAR INFECTION 1
172 EJECTION FRACTION DECREASED 1
173 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1
174 EMOTIONAL DISORDER 1
175 EOSINOPHIL COUNT INCREASED 1
176 EPILEPSY 1
177 EXPULSION OF MEDICATION 1
178 EYE IRRITATION 1
179 EYE PRURITUS 1
180 EYELASH DISCOLOURATION 1
181 FACIAL PARESIS 1
182 FALL 1
183 FEELING JITTERY 1
184 FLUSHING 1
185 GASTRIC HAEMORRHAGE 1
186 GASTROINTESTINAL HAEMORRHAGE 1
187 GINGIVAL BLEEDING 1
188 GINGIVAL HYPERTROPHY 1
189 GRANULOCYTE COUNT DECREASED 1
190 HAEMATOCRIT DECREASED 1
191 HAEMATURIA 1
192 HAEMODILUTION 1
193 HAEMOLYTIC ANAEMIA 1
194 HAEMOPTYSIS 1
195 HAEMORRHAGIC DIATHESIS 1
196 HAND-FOOT-AND-MOUTH DISEASE 1
197 HEAVY MENSTRUAL BLEEDING 1
198 HEPATIC ENZYME INCREASED 1
199 HOSPITALISATION 1
200 HYDROCEPHALUS 1
201 HYPERAEMIA 1
202 HYPERFIBRINOGENAEMIA 1
203 HYPERSENSITIVITY 1
204 HYPERSOMNIA 1
205 HYPERURICAEMIA 1
206 HYPOCALCAEMIA 1
207 HYPOMAGNESAEMIA 1
208 HYPOPHAGIA 1
209 HYPOPITUITARISM 1
210 HYPOTHALAMIC OBESITY 1
211 HYPOXIA 1
212 IMPAIRED HEALING 1
213 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
214 INFECTION 1
215 INFLUENZA 1
216 INFLUENZA LIKE ILLNESS 1
217 INTERCEPTED PRODUCT DISPENSING ERROR 1
218 INTERNATIONAL NORMALISED RATIO INCREASED 1
219 INTERSTITIAL LUNG DISEASE 1
220 INTESTINAL OBSTRUCTION 1
221 IRRITABILITY 1
222 ISCHAEMIC STROKE 1
223 JAUNDICE 1
224 LARYNGOSPASM 1
225 LIGAMENT SPRAIN 1
226 LIP DRY 1
227 MALIGNANT NEOPLASM PROGRESSION 1
228 MEAN CELL VOLUME INCREASED 1
229 MENSTRUATION IRREGULAR 1
230 MONOPARESIS 1
231 MOOD SWINGS 1
232 MUCOCUTANEOUS TOXICITY 1
233 MUCOSAL INFLAMMATION 1
234 MUSCLE SPASMS 1
235 MUSCULAR WEAKNESS 1
236 MUSCULOSKELETAL PAIN 1
237 MYDRIASIS 1
238 MYOSCLEROSIS 1
239 NAIL INFECTION 1
240 NASOPHARYNGITIS 1
241 NEOPLASM PROGRESSION 1
242 NERVOUSNESS 1
243 NEUROPATHY PERIPHERAL 1
244 NEUTROPENIA 1
245 NEUTROPHILIA 1
246 OCULAR ROSACEA 1
247 OESOPHAGEAL HAEMORRHAGE 1
248 OSTEOPENIA 1
249 OXYGEN SATURATION DECREASED 1
250 PANNICULITIS 1
251 PAPULE 1
252 PARTIAL SEIZURES 1
253 PERIORBITAL PAIN 1
254 PERIPHERAL VEIN THROMBOSIS 1
255 PETECHIAE 1
256 PLATELET COUNT DECREASED 1
257 PNEUMOCOCCAL BACTERAEMIA 1
258 PNEUMOCOCCAL SEPSIS 1
259 PNEUMONIA NECROTISING 1
260 PNEUMONITIS 1
261 POLLAKIURIA 1
262 POST PROCEDURAL COMPLICATION 1
263 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1
264 PRODUCT DISPENSING ERROR 1
265 PRODUCT GEL FORMATION 1
266 PRODUCT PACKAGING QUANTITY ISSUE 1
267 PRODUCT USE IN COUNTRY WHERE PRODUCT IS UNAPPROVED 1
268 PRODUCT USE IN UNAPPROVED INDICATION 1
269 PROTHROMBIN TIME PROLONGED 1
270 PROTHROMBIN TIME SHORTENED 1
271 PSYCHOMOTOR HYPERACTIVITY 1
272 PSYCHOMOTOR RETARDATION 1
273 PULMONARY EMBOLISM 1
274 RASH ERYTHEMATOUS 1
275 RASH PAPULAR 1
276 RASH PRURITIC 1
277 REFUSAL OF TREATMENT BY PATIENT 1
278 RENAL IMPAIRMENT 1
279 RESPIRATORY DEPRESSION 1
280 RESPIRATORY FAILURE 1
281 RESPIRATORY SYMPTOM 1
282 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 1
283 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1
284 RETINAL VEIN OCCLUSION 1
285 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 1
286 RIB FRACTURE 1
287 SCRATCH 1
288 SEDATION 1
289 SEPTIC SHOCK 1
290 SHUNT MALFUNCTION 1
291 SPEECH DISORDER 1
292 SPINAL FRACTURE 1
293 STEVENS-JOHNSON SYNDROME 1
294 STREPTOCOCCAL BACTERAEMIA 1
295 SUBARACHNOID HAEMATOMA 1
296 SUBARACHNOID HAEMORRHAGE 1
297 SURGERY 1
298 TACHYCARDIA 1
299 THERAPY CESSATION 1
300 THIRST 1
301 THROAT IRRITATION 1
302 THUNDERCLAP HEADACHE 1
303 THYMUS ENLARGEMENT 1
304 TONGUE DISORDER 1
305 TOXIC SHOCK SYNDROME STREPTOCOCCAL 1
306 TOXICITY TO VARIOUS AGENTS 1
307 TRANSAMINASES INCREASED 1
308 TREMOR 1
309 TUMOUR PSEUDOPROGRESSION 1
310 TYMPANIC MEMBRANE PERFORATION 1
311 UNDERDOSE 1
312 URINARY RETENTION 1
313 URINARY TRACT INFECTION 1
314 URTICARIA 1
315 UVEITIS 1
316 VAGINAL HAEMORRHAGE 1
317 VERTIGO 1
318 VISION BLURRED 1
319 VITAMIN D DECREASED 1
320 WOUND HAEMORRHAGE 1
321 XEROSIS 1